Novel insights into human T‐lymphotropic virus type‐1 (HTLV‐1) pathogenesis‐host interactions in the manifestation of HTLV‐1‐associated myelopathy/tropical …
S Ahmadi Ghezeldasht, A Mosavat… - Reviews in Medical …, 2024 - Wiley Online Library
Human T‐lymphotropic virus type‐1 (HTLV‐1) was the first discovered human oncogenic
retrovirus, the etiological agent of two serious diseases have been identified as adult T‐cell …
retrovirus, the etiological agent of two serious diseases have been identified as adult T‐cell …
Advances in the treatment of human T-cell lymphotropic virus type-I associated myelopathy
ABSTRACT Introduction Nearly 2–3% of those 10 to 20 million individuals infected with the
Human T-cell lymphotropic virus type-1 (HTLV-1); are predisposed to developing HTLV-1 …
Human T-cell lymphotropic virus type-1 (HTLV-1); are predisposed to developing HTLV-1 …
Gene expression study of host-human T-cell leukaemia virus type 1 (HTLV-1) interactions: adult T-cell leukaemia/lymphoma (ATLL)
M Rahimzada, M Nahavandi, M Saffari… - Molecular Biology …, 2023 - Springer
Background In HTLV-1-associated malignant disease, adult T-cell leukaemia/lymphoma
(ATLL), the interaction of virus and host was evaluated at the chemokines gene expression …
(ATLL), the interaction of virus and host was evaluated at the chemokines gene expression …
Cannabinoid receptors as new targets for HTLV-1 associated myelopathy (HAM/TSP) treatment
A Fadaee, FS Mohammadi, N Ariaee… - Multiple Sclerosis and …, 2024 - Elsevier
Abstract Background/Aim The roles of endocannabinoids are described in immune
modulation and neuroprotection. HTLV-1-associated myelopathy (HAM/TSP) is an …
modulation and neuroprotection. HTLV-1-associated myelopathy (HAM/TSP) is an …
[PDF][PDF] A Comprehensive In Silico Study of the NDB-IL-24 Fusion Protein for Tumor Targeting: A Promising Anti-Cancer Therapeutic Candidate
HM Rehman, W Shoaib, MN Khan… - JOURNAL OF …, 2024 - researchgate.net
Background: Breast cancer remains a pervasive global health concern among women, with
conventional therapies such as chemotherapeutic agents, radiography, and surgery lacking …
conventional therapies such as chemotherapeutic agents, radiography, and surgery lacking …
Diseases caused by human T-lymphotropic virus type 1 (HTLV-1)
LV Radygina, LV Mochalova - … Independent Research Journal …, 2024 - scienceopen.com
INTRODUCTION: Human T-lymphotropic virus type 1 (HTLV-1) belongs to the Retroviridae
family (genus Deltaretrovirus) and is directly involved in carcinogenesis. The HTLV-1 …
family (genus Deltaretrovirus) and is directly involved in carcinogenesis. The HTLV-1 …
Заболевания, ассоциированные с Т-лимфотропным вирусом типа 1 человека (HTLV-1) Translated title: Diseases caused by human T-lymphotropic virus type 1 …
ЛВ Радыгина, ЛВ Мочалова - … Independent Research Journal …, 2024 - scienceopen.com
ВВЕДЕНИЕ: Т-лимфотропный вирус типа 1 человека (HTLV-1) относится к семейству
Retroviridae (род Deltaretrovirus) и напрямую участвует в канцерогенезе. Геном HTLV-1 …
Retroviridae (род Deltaretrovirus) и напрямую участвует в канцерогенезе. Геном HTLV-1 …
[引用][C] Impacto de la reactivación por Herpesvirus en el desenlace de pacientes con Linfoma no Hodgkin de estirpe T de un instituto especializado, 2015-2020
SA Criado Martinez - 2024 - repositorio.upsjb.edu.pe
Introducción: El Linfoma no Hodgkin de estirpe T acoge un subgrupo del Linfoma no
Hodgkin que abarca el 10-15% de esta patología. En esta población de pacientes es común …
Hodgkin que abarca el 10-15% de esta patología. En esta población de pacientes es común …